X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with TTK HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TTK HEALTHCARE - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE TTK HEALTHCARE CADILA HEALTHCARE/
TTK HEALTHCARE
 
P/E (TTM) x 32.5 32.9 98.7% View Chart
P/BV x 6.4 6.1 106.2% View Chart
Dividend Yield % 0.7 0.5 152.5%  

Financials

 CADILA HEALTHCARE   TTK HEALTHCARE
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-17
TTK HEALTHCARE
Mar-14
CADILA HEALTHCARE/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs460663 69.3%   
Low Rs305399 76.4%   
Sales per share (Unadj.) Rs92.1535.6 17.2%  
Earnings per share (Unadj.) Rs14.815.9 92.9%  
Cash flow per share (Unadj.) Rs18.520.0 92.3%  
Dividends per share (Unadj.) Rs3.204.00 80.0%  
Dividend yield (eoy) %0.80.8 111.1%  
Book value per share (Unadj.) Rs68.0137.6 49.4%  
Shares outstanding (eoy) m1,023.747.77 13,175.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.21.0 418.7%   
Avg P/E ratio x25.833.3 77.5%  
P/CF ratio (eoy) x20.726.5 78.0%  
Price / Book Value ratio x5.63.9 145.8%  
Dividend payout %21.625.1 86.1%   
Avg Mkt Cap Rs m391,5814,127 9,487.3%   
No. of employees `00016.91.7 986.8%   
Total wages/salary Rs m15,002607 2,473.1%   
Avg. sales/employee Rs Th5,594.52,436.7 229.6%   
Avg. wages/employee Rs Th890.1355.2 250.6%   
Avg. net profit/employee Rs Th899.972.5 1,240.6%   
INCOME DATA
Net Sales Rs m94,2954,162 2,265.7%  
Other income Rs m1,28661 2,101.3%   
Total revenues Rs m95,5814,223 2,263.3%   
Gross profit Rs m19,036197 9,658.0%  
Depreciation Rs m3,75032 11,829.7%   
Interest Rs m45030 1,505.0%   
Profit before tax Rs m16,122197 8,196.2%   
Minority Interest Rs m3380-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-30-   
Tax Rs m1,28973 1,770.6%   
Profit after tax Rs m15,168124 12,242.1%  
Gross profit margin %20.24.7 426.3%  
Effective tax rate %8.037.0 21.6%   
Net profit margin %16.13.0 540.3%  
BALANCE SHEET DATA
Current assets Rs m60,2231,629 3,697.6%   
Current liabilities Rs m53,0581,058 5,015.9%   
Net working cap to sales %7.613.7 55.4%  
Current ratio x1.11.5 73.7%  
Inventory Days Days7030 234.5%  
Debtors Days Days8834 262.5%  
Net fixed assets Rs m72,984556 13,119.5%   
Share capital Rs m1,02478 1,317.9%   
"Free" reserves Rs m68,576878 7,807.8%   
Net worth Rs m69,6001,069 6,508.9%   
Long term debt Rs m24,684159 15,553.9%   
Total assets Rs m152,2072,399 6,343.5%  
Interest coverage x36.87.6 485.9%   
Debt to equity ratio x0.40.1 239.0%  
Sales to assets ratio x0.61.7 35.7%   
Return on assets %10.36.4 160.1%  
Return on equity %21.811.6 188.1%  
Return on capital %17.918.5 97.2%  
Exports to sales %00.8 0.0%   
Imports to sales %01.4 0.0%   
Exports (fob) Rs mNA33 0.0%   
Imports (cif) Rs mNA58 0.0%   
Fx inflow Rs m21,28033 64,680.9%   
Fx outflow Rs m10,87463 17,208.4%   
Net fx Rs m10,406-30 -34,354.6%   
CASH FLOW
From Operations Rs m13,495127 10,659.6%  
From Investments Rs m-29,103-146 19,933.6%  
From Financial Activity Rs m23,15822 105,744.3%  
Net Cashflow Rs m7,5563 302,240.0%  

Share Holding

Indian Promoters % 74.8 65.4 114.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 3.7 224.3%  
FIIs % 5.9 5.2 113.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 25.8 42.6%  
Shareholders   44,069 12,723 346.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  WOCKHARDT LTD.  ABBOTT INDIA  DR. DATSONS LABS  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; IT Stocks Top Gainers(01:30 pm)

After opening the day marginally higher, share markets in India continued the momentum and are presently trading in green. Sectoral indices are trading on a mixed note, with stocks in the IT sector.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 22, 2018 03:33 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS